 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
With New Tg Test, Quest Continues to Push Mass Spec-Based Protein Assays Toward Clinical Viability
June 22, 2012
With New Tg Test, Quest Continues to Push Mass Spec-Based Protein Assays Toward Clinical Viability
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- MDx Highlights from the American Society of Clinical Oncology's 2012 Meeting
June 13, 2012 / Pharmacogenomics Reporter - Q&A: Jamie Platt of Quest Dx's Nichols Institute on Sample Prep in Clinical Sequencing
May 9, 2013 / PCR Insider - Quest Enters into Agreement to Buy Back $450M of Stock
April 23, 2013 / GenomeWeb Daily News - Quest Launches Pair of Rheumatoid Arthritis Biomarker Tests Based on Protein Licensed from Augurex
April 12, 2013 / ProteoMonitor - Matrix-Bio Licenses Metabolomic Biomarkers to Quest for Breast Cancer Test Development
April 11, 2013 / GenomeWeb Daily News